Duration of IOP Reduction With Travoprost BAK-free Solution

200858 citationsJournal Article

Authors

Ronald L. Gross · Baylor College of Medicine

James H. Peace

Stephen Smith · Clinical Physiology Associates

Thomas R. Walters · Texan Eye

Harvey Dubiner · Clayton Eye Center

Mark J. Weiss

Katherine I. Ochsner

Abstract

Travoprost without BAK has similar IOP-lowering efficacy and safety compared with travoprost preserved with BAK. Both formulations of travoprost have a prolonged duration of action, with statistically and clinically significant reductions from baseline persisting up to 60 hours after the last dose.

Topics & Keywords

Glaucoma and retinal disorders Ocular Surface and Contact Lens Corneal surgery and disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Glaucoma

Volume 17, Issue 3, pp. 217-222

DOI: 10.1097/ijg.0b013e31815a3472

Field-Weighted Citation Impact: 8.19